• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES Back to Search Results
Model Number CDS0701-XT
Device Problem Off-Label Use (1494)
Patient Problems Tissue Damage (2104); Tricuspid Regurgitation (2112)
Event Date 12/17/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The clip remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The additional device referenced is filed under a separate medwatch report number.
 
Event Description
This is being filed to report the clip causing damage to the leaflet and increased tr.It was reported that the initial mitraclip procedure was performed on (b)(6) 2020, to treat tricuspid regurgitation (tr) with a grade of 4+.Patient was severely diuresed before procedure to lessen coaptation gap of tr.Three clips were implanted, reducing tr to 1.The patient returned on a later date and transesophageal echocardiography (tee) observed the tr had increased to 4 and that two of the clips had torn through the anterior leaflet.The clip were still attached to both leaflets.According to the physician, after the patient¿s procedure, the patient was given fluid volume on the floor and became volume overloaded.The thought was that because they were diuresed prior, the overload of volume put too much immediate stress on leaflets causing a tear.No further treatment was planned.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.It should be noted that per the mitraclip system instructions for use (ifu), indication for use section states: the mitraclip g4 system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation.The off-label use does not appear to have contributed to the reported patient effects.The reported patient effect of tissue damage appears to have been a result of procedural conditions.The reported patient effect of recurrent tr appears to have been a cascading event of the reported tissue damage.Additionally, the reported patient effect of tissue damage as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP G4 CLIP DELIVERY SYSTEM
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11135280
MDR Text Key225733036
Report Number2024168-2021-00237
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648230981
UDI-Public08717648230981
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/17/2021
Device Model NumberCDS0701-XT
Device Catalogue NumberCDS0701-XT
Device Lot Number00818U104
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/17/2020
Initial Date FDA Received01/07/2021
Supplement Dates Manufacturer Received01/08/2021
Supplement Dates FDA Received01/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
2 IMPLANTED MITRACLIPS
Patient Outcome(s) Other;
Patient Age97 YR
Patient Weight67
-
-